About
Precision Cardiovascular is a private limited company based in Harefield, England, established in April 2021. The company focuses on research and development in cardiovascular health technologies. It specializes in an AI-powered system designed for continuous heart failure management. Their flagship product is a minimally invasive sensor device that monitors pulmonary artery pressure (PAP) and is implanted through an outpatient procedure. This device works alongside a chest patch that captures real-time readings, which are transmitted remotely. A dedicated app analyzes patient data, allowing for seamless remote monitoring and providing clinicians with actionable insights to enhance patient care. This technology addresses key limitations of traditional heart failure monitoring by capturing daily fluctuations in PAP, enabling personalized care for different heart failure patient types. Led by a team of experts, including CEO Mohamed Abou-Alam and Clinical Director Prof. Sir Magdi Yacoub, Precision Cardiovascular aims to empower clinicians and healthcare providers with precise, real-time cardiovascular insights to improve patient outcomes. The company is supported by prominent partners and investors, highlighting its strong foundation in the medtech field.
Technologies
Keywords
Company Information
-
Employees 13
-
Founded 2021
-
Total Funding $750000
Location
Hill End Road, Harefield, England, United Kingdom, UB9 6JH
